This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
Xu LP, Lu PH, Wu DP, Sun ZM, Liu QF, Han MZ, et al. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transpl. 2021;56:2940–7.
Klein J, Sato A. The HLA system. First of two parts. N. Engl J Med. 2000;343:702–9.
Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med. 2008;205:725–35.
Das J, Khakoo SI. NK cells: tuned by peptide? Immunol Rev. 2015;267:214–27.
Merino AM, Sabbaj S, Easlick J, Goepfert P, Kaslow RA, Tang J. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clin Exp Immunol. 2013;174:414–23.
Sajulga R, Bolon YT, Maiers MJ, Petersdorf EW. Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation. Blood Adv. 2022;6:270–80.
Petersdorf EW, Carrington M, O’HUigin C, Bengtsson M, De Santis D, Dubois V, et al. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study. Lancet Haematol. 2020;7:e50–e60.
Petersdorf EW, Stevenson P, Bengtsson M, De Santis D, Dubois V, Gooley T, et al. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation. Blood. 2020;136:362–9.
Petersdorf EW, Gooley T, Volt F, Kenzey C, Madrigal A, McKallor C, et al. Use of the HLA-B leader to optimize cord blood transplantation. Haematologica. 2021;106:3107–14.
Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MR, Modi D, et al. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide. Blood. 2022;139:1452–68.
Dahlberg A, Milano F. Cord blood transplantation: rewind to fast forward. Bone Marrow Transpl. 2017;52:799–802.
Ando T, Tachibana T, Tanaka M, Suzuki T, Ishiyama Y, Koyama S, et al. Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation. Blood Adv. 2020;4:408–19.
This work was supported by grants from the National Nature Science Foundation of China (No. 82170217 to AP, No. 82070192 and No. 81670171 to EJ), Haihe Laboratory of Cell Ecosystem Innovation Fund (No. HH22KYZX0034 to EJ), Fundamental Research Funds for the central universities (No. 3332020052 to YC), CAMS Innovation Fund for Medical Sciences (No. 2021-I2M-1-073 to AP), and Key Project of Tianjin Natural Science Foundation (No. 20JCZDJC00410 to AP).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, M., Guo, W., Zheng, X. et al. Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning. Bone Marrow Transplant 58, 94–96 (2023). https://doi.org/10.1038/s41409-022-01842-z